tiprankstipranks
AMCO United Holding Limited (HK:0630)
:0630
Hong Kong Market

AMCO United Holding (0630) AI Stock Analysis

Compare
0 Followers

Top Page

HK:0630

AMCO United Holding

(0630)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
HK$0.24
▼(-2.80% Downside)
Action:ReiteratedDate:12/30/25
The score is held back primarily by weak financial quality (ongoing net losses and negative operating/free cash flow in 2023–2024) and bearish technical signals (price below key moving averages with a negative MACD). A relatively low P/E provides some valuation support, but not enough to offset the profitability and cash-generation risks.
Positive Factors
Revenue Growth
The significant revenue growth indicates a recovery and potential expansion in market reach, which is crucial for long-term business sustainability.
Negative Factors
Negative Profitability
Ongoing net losses indicate challenges in achieving profitability, which could hinder long-term financial health and investment capacity.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The significant revenue growth indicates a recovery and potential expansion in market reach, which is crucial for long-term business sustainability.
Read all positive factors

AMCO United Holding (0630) vs. iShares MSCI Hong Kong ETF (EWH)

AMCO United Holding Business Overview & Revenue Model

Company Description
AMCO United Holding Limited, an investment holding company, manufactures and sells medical devices and plastic molding products in Hong Kong and internationally. It also offers construction services in the areas of building construction, building ...
How the Company Makes Money
AMCO United Holding Limited primarily generates revenue through the manufacturing and trading of medical and healthcare products. This involves producing and distributing a range of medical devices and healthcare-related items to various markets. ...

AMCO United Holding Financial Statement Overview

Summary
Mixed fundamentals: revenue rebounded in 2024 (+14.2% YoY) and the business improved versus the extreme 2022 loss, but profitability remains negative (net income still negative in 2023–2024) with weaker margins in 2024. The balance sheet leverage is moderate recently (debt-to-equity ~0.50), yet operating and free cash flow are negative in both 2023 and 2024, indicating ongoing cash consumption.
Income Statement
46
Neutral
Balance Sheet
58
Neutral
Cash Flow
32
Negative
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue42.93M37.79M34.33M66.49M71.89M53.77M
Gross Profit15.53M10.97M14.81M14.69M14.12M13.30M
EBITDA22.71M2.00M9.19M-102.84M-14.73M-31.44M
Net Income25.34M-1.23M-2.75M-104.25M-18.11M-34.97M
Balance Sheet
Total Assets180.79M159.33M168.72M172.84M184.78M212.76M
Cash, Cash Equivalents and Short-Term Investments81.84M63.96M53.18M39.75M47.31M28.10M
Total Debt33.09M30.90M30.90M31.34M34.32M34.09M
Total Liabilities119.52M99.20M107.36M154.25M69.95M80.66M
Stockholders Equity61.28M60.13M61.36M18.59M114.82M132.09M
Cash Flow
Free Cash Flow-780.00K-4.64M-8.77M-30.04M4.00M-26.94M
Operating Cash Flow-780.00K-4.64M-8.77M-30.04M5.40M-26.94M
Investing Cash Flow-586.00K1.51M14.00K2.00K-1.31M-33.75M
Financing Cash Flow3.00M0.0012.75M28.97M-3.44M53.61M

AMCO United Holding Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.25
Price Trends
50DMA
0.25
Positive
100DMA
0.27
Positive
200DMA
0.27
Positive
Market Momentum
MACD
<0.01
Negative
RSI
68.54
Neutral
STOCH
94.58
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0630, the sentiment is Positive. The current price of 0.25 is above the 20-day moving average (MA) of 0.23, above the 50-day MA of 0.25, and below the 200-day MA of 0.27, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 68.54 is Neutral, neither overbought nor oversold. The STOCH value of 94.58 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0630.

AMCO United Holding Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
53
Neutral
HK$402.54M-21.76-7.33%11.32%62.61%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
HK$339.04M24.140.23%2.45%-1.50%-96.83%
49
Neutral
HK$261.45M-0.28-30.56%30.86%-67.89%
46
Neutral
HK$1.26B1.27-3.32%3.80%10.38%7.39%
46
Neutral
HK$87.98M-0.13-77.60%-19.75%31.54%
44
Neutral
HK$261.24M56.9141.75%29.77%1646.67%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0630
AMCO United Holding
0.26
0.20
333.33%
HK:1222
Wang On Group Limited
0.02
>-0.01
-8.70%
HK:0025
Chevalier International Holdings Limited
4.17
0.33
8.59%
HK:2700
Green International Holdings Limited
0.61
0.15
32.61%
HK:0132
China Investments Holdings Limited
0.20
-0.06
-23.85%
HK:0138
CCT Fortis Holdings Limited
0.55
-0.35
-38.89%

AMCO United Holding Corporate Events

AMCO United Holding’s Strategic Shift Spurs Growth in Medical Device Sector
Dec 4, 2025
AMCO United Holding Limited reported a significant shift in its revenue composition for FY2024, with a notable decline in sales of COVID-19-related products and traditional lancet devices due to post-pandemic market normalization and increased com...
AMCO United Holding Appoints Ms. Li Sisi as Independent Director
Nov 14, 2025
AMCO United Holding Limited has appointed Ms. Li Sisi as an independent non-executive director and member of its audit, remuneration, and nomination committees, effective November 14, 2025. Ms. Li, a seasoned professional with a background in info...
AMCO United Holding Announces Board and Committee Roles
Nov 14, 2025
AMCO United Holding Limited has announced the composition of its board of directors and the roles within its committees. The board includes both executive and independent non-executive directors, with Mr. Jia Minghui serving as Chairman. The compa...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025